Research
Note: The links for “Time capsuled code” provide code for reproducing the numerical results of each paper.
\(\dagger\) Co-first authors, equal contribution.
Laha N., Koner, S., Labowitz A., and De Sarkar N. (2026). False discovery rate control: Moving beyond the Benjamini–Hochberg method. PeerJ.
Link: Manuscript. Link: Code (R code).Koner S. (2026). Book review: Introduction to Quantitative Social Science with Python. Journal of the American Statistical Association, 1727-1728
Link: Manuscript.Alam S., Choi D., Koner S. and Luo S. (2025). Dynamic Prediction Using Functional Latent Trait Joint Models for Multivariate Longitudinal Outcomes: An Application to Parkinson’s Disease Statistics in Medicine.
Link: Manuscript.Koner S. and Luo S. (2025). Power and sample size calculation for Two-Sample projection-based testing of sparsely observed functional data. Stat.
Link: Manuscript. Link: R package fPASS.Koner S. and Luo S. (2024). Projection-based two-sample inference for sparsely observed multivariate functional data. Biostatistics.
Link: Manuscript. Link: Time capsuled code (R code).Koner S, Park S.Y., and Staicu A.M. (2024). PROFIT: Projection-based Test in Longitudinal Functional Data. Journal of Nonparametric Statistics, 1-28.
Link: Manuscript. Link: Time capsuled code (R code).Koner S. and Staicu A.M. (2023). Second-Generation Functional Data. Annual Review of Statistics and Its Application Vol. 10:547-572.
Link: Manuscript.Koner S. and Williams J. P. (2023). The EAS approach to variable selection for multivariate response data in high-dimensional settings. Electronic Journal of Statistics.
Link: Manuscript. Link: Time capsuled code (R code).Li H.\(^\dagger\), Wu Y.\(^\dagger\), Zou H.\(^\dagger\), Koner S.\(^\dagger\), Plichta J K., Tolaney S M., Zhang J., He Y-W., Wei Q., Tang L., Zhang H., Zhang B., Guo Y., Chen X., Li K., Lian L., Ma F., and Luo S. (2024) Clinical efficacy of CDK4/6 inhibitor plus endocrine therapy in HR-positive/HER2-0 and HER2-low-positive metastatic breast cancer: a secondary analysis of PALOMA-2 and PALOMA-3 trials. Ebiomedicine, Vol 105
Link: Manuscript